Table 2.

Implication of clinicopathological items in forecasting 3‐y survival of nasopharyngeal carcinoma patients

Clinco‐pathological items	Number of cases (n)	Univariate		P	Multivariate		P
		HR	95% CI		HR	95% CI
Age (years old, n)
<55	99
≥55	142	1.023	0.710‐1.472	.904	0.99	0.687‐1.439	.976
Gender (n)
Male	122
Female	119	1.21	0.847‐1.729	.296	1.21	0.841‐1.742	.304
Histological type (n)
Differentiated non‐keratinizing carcinoma	21
Undifferentiated carcinoma	220	1.032	0.540‐1.971	.924	1.089	0.563‐2.106	.800
Clinical staging (n)
I‐II	59
III‐IV	182	1.857	1.137‐3.033	.013	1.371	0.829‐2.269	.219
Depth of infiltration (n)
T1 + T2	109
T3 + T4	132	1.91	1.31‐2.785	.001	1.76	1.194‐2.594	.004*
Lymph‐node metastasis (n)
Yes	185
No	56	3.004	1.654‐5.456	<.001	2.256	1.212‐4.201	.010*
Relative expression of hsa_circ_0028007 (n)
Under‐expression	160
Over‐expression	81	2.55	1.605‐4.053	<.001	1.738	1.067‐2.831	.026*

Abbreviations: CI, confidence interval; HR, hazard ratio.

^*Statistical significance.